Tag

Allergan

All articles tagged with #allergan

business2 years ago

AbbVie's Key Drugs Underperform, Stock Falls.

AbbVie's Q1 2023 financials showed lower than expected sales for potential replacements for its blockbuster arthritis therapy Humira, Skyrizi and Rinvoq, leading to a ~6% pre-market drop in the company's stock. Despite global Humira sales falling ~25% YoY, the company reported $12.3B revenue for the quarter, in line with expectations. AbbVie's hematologic oncology portfolio generated $1.4B in revenue with a ~14% YoY drop, while the Botox therapy acquired from its 2020 Allergan acquisition outperformed, bringing $719M and $659M for the company's neuroscience and aesthetics portfolios with ~17% YoY and ~3% YoY growth, respectively.

health2 years ago

Beauty Treatment Gone Wrong: Disfigurement Caused by Fat-Zapping Procedure.

CoolSculpting, a medical device that freezes fat cells, has generated over $2 billion in revenue, but for some patients, it can result in severe disfigurement due to a side effect called paradoxical adipose hyperplasia (PAH). Allergan Aesthetics, the company that owns CoolSculpting, claims that PAH occurs in only 0.033% of treatments, but a New York Times investigation suggests that the risk may be considerably higher. The company has restricted patients from talking about the problem through confidentiality agreements and stopped reporting the side effect to federal regulators. Patients with PAH may require surgery to correct the disfigurement, which can cost tens of thousands of dollars and leave scars.

health2 years ago

Beauty Treatment Gone Wrong: Disfigurement Caused by Fat-Zapping Procedure.

CoolSculpting, a medical device that freezes fat cells, has generated over $2 billion in revenue, but for some patients, it can result in severe disfigurement. The side effect, called paradoxical adipose hyperplasia (PAH), occurs when the fat grows, hardens, and lodges in the body, sometimes even taking on the shape of the device's applicator. Allergan Aesthetics, the company that owns CoolSculpting, says the risk is rare, occurring in 0.033% of treatments, but a New York Times examination indicates that the risk may be considerably higher. Some patients have had to undergo multiple surgeries to correct the issue, and Allergan has offered to help cover the costs, contingent on signing a confidentiality agreement.